Fig. 3: Expression of B7-H3 in different tumor types and the relationship between B7-H3 expression and response.
From: A B7H3-targeting antibody–drug conjugate in advanced solid tumors: a phase 1/1b trial
a, Expression of B7H3 in different tumor types. b–f, The relationship between B7-H3 expression and response in all patients (b), ES-SCLC (c), NPC (d), ESCC (e) and LELC (f). The median, quartile, and maximum and minimum values are shown. Comparisons were performed using Kruskal–Wallis one-way ANOVA tests. NE, not evaluated; cBOR, confirmed best overall response.